23 May 2013
Keywords: merck, co, emend, cleared, fda, nausea, cancer
Article | 07 April 2003
Merck & Co has been granted approval by the US Food and DrugAdministration for Emend (aprepitant), its new drug for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 April 2003
22 May 2013
© 2013 thepharmaletter.com